Medicinal Plants and Herbal Products From Brazil: How Can We Improve Quality?

Autor: Rafael Melo Palhares, Fernanda. L. B. Mügge, Marina Scopel, Maria G.L. Brandão, Leopoldo Clemente Baratto
Rok vydání: 2021
Předmět:
Zdroj: Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2021)
ISSN: 1663-9812
DOI: 10.3389/fphar.2020.606623
Popis: Brazil has widely diverse flora, rich in medicinal plants, which are an important part of the Amerindian traditional knowledge (Levis et al., 2017). Some Brazilian plants were included decades ago in different Pharmacopoeias because they provide important substances used in medical practice worldwide. Examples are Carapichea ipecacuanha (Brot.) L. Andersson (ipecac), source of the emetic and amoebicide alkaloid emetine, and Pilocarpus microphyllus Stapf ex Wardlew, source of the antiglaucoma pilocarpine (Nogueira et al., 2010). More recently, Acai (Euterpe oleracea Mart.), native from the Amazon rainforest, became notorious in the international market as a nutraceutical (Carey et al., 2017). Despite its potential, the native vegetation of Brazil has been undergoing intense destruction: all the ecosystems, including the Amazon rainforest, have been quickly replaced by monocultures of sugarcane, soybeans, eucalyptus, and livestock, leading to an intense process of genetic and cultural erosion. On the other side, more recently, the development of bioproducts from Brazilian plants has been stimulated, aiming at a market based in the bioeconomy, which not only brings health benefits but also is important for conservation of biodiversity and consequent mitigation of climate changes (Dinerstein et al., 2020). However, due to the current precarious situation of the herbal products market in Brazil, many steps need to be taken until such a goal is achieved.
Databáze: OpenAIRE